These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 17886199)
21. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099 [TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841 [TBL] [Abstract][Full Text] [Related]
23. A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. Leal YA; Gómez A; Madrazo-de la Garza A; Ramos I; Muñoz O; Torres J Rev Invest Clin; 2008; 60(6):470-7. PubMed ID: 19378833 [TBL] [Abstract][Full Text] [Related]
24. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Magen E; Mishal J; Schlesinger M; Scharf S Helicobacter; 2007 Oct; 12(5):567-71. PubMed ID: 17760727 [TBL] [Abstract][Full Text] [Related]
25. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [TBL] [Abstract][Full Text] [Related]
26. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993 [TBL] [Abstract][Full Text] [Related]
27. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy]. Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513 [TBL] [Abstract][Full Text] [Related]
28. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934 [TBL] [Abstract][Full Text] [Related]
29. Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication. Wu DC; Wu IC; Wang SW; Lu CY; Ke HL; Yuan SS; Wang YY; Chang WH; Wang TE; Bair MJ; Kuo FC Diagn Microbiol Infect Dis; 2006 Dec; 56(4):373-8. PubMed ID: 17157673 [TBL] [Abstract][Full Text] [Related]
30. An evaluation of a serologic test with a current infection marker of Helicobacter pylori before and after eradication therapy in Chinese. Wang XY; Yang Y; Shi RH; Ho B; Wang HD; Zhang GX Helicobacter; 2008 Feb; 13(1):49-55. PubMed ID: 18205666 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489 [TBL] [Abstract][Full Text] [Related]
32. [The appropriate time for the assessment of Helicobacter pylori eradication]. Ishizuka J; Kato M; Sugiyama T; Asaka M Nihon Rinsho; 1999 Jan; 57(1):111-5. PubMed ID: 10036946 [TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values. Gisbert JP; Olivares D; Jimenez I; Pajares JM Aliment Pharmacol Ther; 2006 Jan; 23(2):275-80. PubMed ID: 16393307 [TBL] [Abstract][Full Text] [Related]
34. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879 [TBL] [Abstract][Full Text] [Related]
35. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Goldman CG; Barrado DA; Balcarce N; Rua EC; Oshiro M; Calcagno ML; Janjetic M; Fuda J; Weill R; Salgueiro MJ; Valencia ME; Zubillaga MB; Boccio JR Nutrition; 2006 Oct; 22(10):984-8. PubMed ID: 16978844 [TBL] [Abstract][Full Text] [Related]
36. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937 [TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection. Kim SY; Hyun JJ; Jung SW; Koo JS; Yim HJ; Lee SW Helicobacter; 2014 Jun; 19(3):202-6. PubMed ID: 24612156 [TBL] [Abstract][Full Text] [Related]
38. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Cai W; Zhou L; Ren W; Deng L; Yu M Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433 [TBL] [Abstract][Full Text] [Related]
39. The effect of gastric Helicobacter pylori eradication on recurrent aphthous stomatitis. Karaca S; Seyhan M; Senol M; Harputluoglu MM; Ozcan A Int J Dermatol; 2008 Jun; 47(6):615-7. PubMed ID: 18477159 [TBL] [Abstract][Full Text] [Related]
40. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]